PhD Viljem Kovač

PhD Viljem Kovač
no.: 16229 source: ARIS

researcher – active in research organisation
  • English
  • Reading: Fluent
  • Writing: Fluent
  • Speaking: Fluent
  • German
  • Reading: Fluent
  • Writing: Basic
  • Speaking: Functional
Edit
Research activity

Code Science Field Subfield
3.00.00  Medical sciences     
3.04.00  Medical sciences  Oncology   
Keywords
Radiotherapy, multimodelity, treatment, lung cancer, mesotelioma, germ cell tumors
Bibliography Representative bibliographic units | Personal | COBISS+
source: COBISS
source: SICRIS
Evaluation (metodology)
Evaluation of bibliographic research performance indicators according to ARIS methodology
source: COBISS
source: ARIS
Points
440.16
A''
0
A'
17.22
A1/2
147.25
CI10
1,031
CImax
292
h10
14
A1
1.28
A3
2.17
Data for the last 5 years (citations for the last 10 years) on November 11, 2025; Data for score A3 calculation refer to period 2020-2024 (2020, 2021, 2022, 2023, 2024)
Data for ARIS tenders ( 21.05.2024 – Target research programmes, archive )
Citations Citations for bibliographic records in COBIB.SI that are linked to records in citation databases
source: WoS source: Scopus source: COBISS
Database Linked records Citations Pure citations Average pure citations
WoS 76  1,738  1,545  20.33 
Scopus 75  2,096  1,896  25.28 
Education
source: ARIS
Level of education Professional title Study subject Faculty Year
Bachelor's degree  Medical doctor  Medicine  SI 1983 
Specialization      SI University of Ljubljana, Faculty of Medicine 1994 
Master's degree  M. Sc.   Oncology  HR 1996 
Doctoral degree  Ph. D.     SI University of Ljubljana, Faculty of Medicine 2011 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group Date of employment Position Role Title
Full time employment (100%, RD:20%)  Institute of Oncology Ljubljana  Department of research  12/15/1986  Consultant in clinical oncology  Researcher  Associate professor 
Research projects Legend
source: ARIS
no. Code Title Period Head
1. L1-60135  Circulating extracellular vesicles as a source of multi-omic biomarkers of development of asbestos-related diseases and treatment response in malignant mesothelioma   1/1/2025 - 12/31/2027  PhD Vita Dolžan   3,323 
2. J3-60064  Molecular biomarkers of response to radiotherapy in ductal carcinoma in situ   1/1/2025 - 12/31/2027  PhD Katja Goričar   1,552 
3. J3-3083  Vascularization and vascular effects as predictive factors for local ablative techniques   10/1/2021 - 9/30/2025  PhD Gregor Serša   7,427 
4. L3-2622  Biological markers of risk for development, progression and treatment response in asbestos related diseases   9/1/2020 - 8/31/2023  PhD Vita Dolžan   3,431 
5. J3-2527  New approaches for prediction of cardiotoxicity in breast cancer radiotherapy   9/1/2020 - 8/31/2023  PhD Tanja Marinko   2,516 
6. J3-1753  Molecular predictors of radiation treatment response in breast cancer   7/1/2019 - 6/30/2022  PhD Katja Goričar   1,793 
7. L3-8203  Serumski, genetski in epigenetski označevalci tveganja za nastanek, napredovanja in odgovora na zdravljenje bolezni povezanih z izpostavljenostjo azbestu (Slovene)   5/1/2017 - 4/30/2020  PhD Vita Dolžan   3,145 
8. J3-7460  Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model   1/1/2016 - 12/31/2018  PhD Primož Strojan   4,631 
9. J3-7372  Molecular biomarkers and biomarker-driven therapy in lung cancer   1/1/2016 - 12/31/2018  PhD Tanja Čufer   5,075 
10. J3-6793  Novi pristopi radiosenzibilizacije tumorjev z gensko terapijo (Slovene)   7/1/2014 - 6/30/2017  PhD Gregor Serša   5,570 
11. J3-2277  Kombinacija elektrogenske imunske terapije z interlevkinom-12 in obsevanjem za zdravljenje eksperimentalnih tumorjev (Slovene)   5/1/2009 - 4/30/2012  PhD Maja Čemažar   3,028 
12. J1-0200  Sinteza novih rutenijevih spojin in njihova možna uporaba pri tumorski elektrokemoterapiji (Slovene)   2/1/2008 - 1/31/2011  PhD Iztok Turel   4,672 
13. L3-0449  New approaches in the treatment of lung cancer II.   2/1/2008 - 1/30/2011  PhD Matjaž Zwitter   2,043 
14. J3-6044  Nove poti zdravljenja pljučnega raka (Slovene)   7/1/2004 - 6/30/2007  PhD Matjaž Zwitter   2,905 
15. L3-3375  Introduction of threedimensional radiotherapy treatment planning in Slovenia   7/1/2001 - 6/30/2004  PhD Hotimir Lešničar   6,392 
16. J3-3489  New biomedical applications of electroporation   7/1/2001 - 6/30/2004  PhD Gregor Serša   4,323 
17. J3-2411  Histološki in imunohistokemični napovedi dejavniki pri karcinomu dojke v stadiju I (Slovene)   1/1/2000 - 6/30/2002  PhD Matej Bračko   2,400 
18. J3-2049  Uporaba elektroporacij v genski terapiji (Slovene)   1/1/2000 - 6/30/2002  PhD Maja Čemažar   4,389 
19. J3-1220  Napovedna vrednost oksigeniranosti tumorjev pri izbranih bolnikih z malignomom glave in vratu (Slovene)   1/1/1999 - 6/30/2001  PhD Hotimir Lešničar   2,604 
20. J3-0143  Raziskave zdravljenja pljučnega raka: etična in klinična razpotja (Slovene)   7/1/1998 - 6/30/2001  PhD Matjaž Zwitter   746 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head
1. P3-0307  Cancer of the head and neck - analysis of biological characteristics and an attempt to improve treatment results   1/1/2019 - 12/31/2027 PhD Primož Strojan   4,538 
2. P3-0307  Cancer of the head and neck - analysis of biological characteristics and an attempt to improve treatment results   1/1/2014 - 12/31/2018 PhD Primož Strojan   4,422 
3. P3-0289  Characteristics of Malignant Neoplasms Important for Diagnosis, Prognosis and Treatment Outcome   1/1/2009 - 12/31/2013 PhD Nikola Bešić   3,832 
Confirmation required
Views history
Favourite